These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 20197629)
1. Long-term clinical outcome of chronic total occlusive lesions treated with drug-eluting stents: comparison of sirolimus-eluting and paclitaxel-eluting stents. Lee SP; Kim SY; Park KW; Shin DH; Kang HJ; Koo BK; Suh JW; Cho YS; Yeon TJ; Chae IH; Choi DJ; Kim HS Circ J; 2010 Apr; 74(4):693-700. PubMed ID: 20197629 [TBL] [Abstract][Full Text] [Related]
2. Comparison of six-year clinical outcome of sirolimus- and paclitaxel-eluting stents to bare-metal stents in patients with ST-segment elevation myocardial infarction: an analysis of the RESEARCH (rapamycin-eluting stent evaluated at Rotterdam cardiology hospital) and T-SEARCH (taxus stent evaluated at Rotterdam cardiology hospital) registries. Simsek C; Magro M; Boersma E; Onuma Y; Nauta S; Daemen J; Gaspersz M; van Geuns RJ; van der Giessen W; van Domburg R; Serruys P J Invasive Cardiol; 2011 Aug; 23(8):336-41. PubMed ID: 21828397 [TBL] [Abstract][Full Text] [Related]
3. Five-year clinical outcomes of a polymer-free sirolimus-eluting stent versus a permanent polymer paclitaxel-eluting stent: final results of the intracoronary stenting and angiographic restenosis - test equivalence between two drug-eluting stents (ISAR-TEST) trial. King L; Byrne RA; Mehilli J; Schömig A; Kastrati A; Pache J Catheter Cardiovasc Interv; 2013 Jan; 81(1):E23-8. PubMed ID: 22431239 [TBL] [Abstract][Full Text] [Related]
4. Long-Term outcome of drug-eluting stents compared with bare metal stents in ST-segment elevation myocardial infarction: results of the paclitaxel- or sirolimus-eluting stent versus bare metal stent in Primary Angioplasty (PASEO) Randomized Trial. Di Lorenzo E; Sauro R; Varricchio A; Carbone G; Cortese G; Capasso M; Lanzillo T; Manganelli F; Mariello C; Siano F; Pagliuca MR; Stanco G; Rosato G; De Luca G Circulation; 2009 Sep; 120(11):964-72. PubMed ID: 19720939 [TBL] [Abstract][Full Text] [Related]
5. The unrestricted use of sirolimus- and paclitaxel-eluting stents results in better clinical outcomes during 6-year follow-up than bare-metal stents: an analysis of the RESEARCH (Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated At Rotterdam Cardiology Hospital) registries. Simsek C; Magro M; Boersma E; Onuma Y; Nauta ST; Gaspersz MP; van der Giessen WJ; van Domburg RT; Serruys PW; JACC Cardiovasc Interv; 2010 Oct; 3(10):1051-8. PubMed ID: 20965464 [TBL] [Abstract][Full Text] [Related]
6. Five-year clinical outcomes after coronary stenting of chronic total occlusion using sirolimus-eluting stents: insights from the rapamycin-eluting stent evaluated at Rotterdam Cardiology Hospital-(Research) Registry. Shen ZJ; García-García HM; Garg S; Onuma Y; Schenkeveld L; van Domburg RT; Serruys PW; Catheter Cardiovasc Interv; 2009 Dec; 74(7):979-86. PubMed ID: 19753636 [TBL] [Abstract][Full Text] [Related]
7. Long-term outcome of the unrestricted use of everolimus-eluting stents compared to sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients: the Bern-Rotterdam diabetes cohort study. Simsek C; Räber L; Magro M; Boersma E; Onuma Y; Stefanini GG; Zanchin T; Kalesan B; Wenaweser P; Jüni P; van Geuns RJ; van Domburg RT; Windecker S; Serruys PW Int J Cardiol; 2013 Dec; 170(1):36-42. PubMed ID: 24196314 [TBL] [Abstract][Full Text] [Related]
8. Sirolimus- versus paclitaxel-eluting stents for the treatment of coronary bifurcations results: from the COBIS (Coronary Bifurcation Stenting) Registry. Song YB; Hahn JY; Choi SH; Choi JH; Lee SH; Jeong MH; Kim HS; Seong IW; Yang JY; Rha SW; Jang Y; Yoon JH; Tahk SJ; Seung KB; Park SJ; Gwon HC J Am Coll Cardiol; 2010 Apr; 55(16):1743-50. PubMed ID: 20394879 [TBL] [Abstract][Full Text] [Related]
9. A randomized comparison of sirolimus- versus paclitaxel-eluting stent implantation in patients with diabetes mellitus: 4-year clinical outcomes of DES-DIABETES (drug-eluting stent in patients with DIABETES mellitus) trial. Lee SW; Park SW; Kim YH; Yun SC; Park DW; Lee CW; Kang SJ; Rhee KS; Chae JK; Ko JK; Park JH; Lee JH; Choi SW; Jeong JO; Seong IW; Cho YH; Lee NH; Kim JH; Chun KJ; Kim HS; Park SJ JACC Cardiovasc Interv; 2011 Mar; 4(3):310-6. PubMed ID: 21435609 [TBL] [Abstract][Full Text] [Related]
10. Impact of vessel size on outcome after implantation of sirolimus-eluting and paclitaxel-eluting stents: a subgroup analysis of the SIRTAX trial. Togni M; Eber S; Widmer J; Billinger M; Wenaweser P; Cook S; Vogel R; Seiler C; Eberli FR; Maier W; Corti R; Roffi M; Lüscher TF; Garachemani A; Hess OM; Wandel S; Meier B; Jüni P; Windecker S J Am Coll Cardiol; 2007 Sep; 50(12):1123-31. PubMed ID: 17868802 [TBL] [Abstract][Full Text] [Related]
11. In-hospital and 1-year outcomes among unselected percutaneous coronary intervention patients treated with either sirolimus- or paclitaxel-eluting stents: results from the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) registry. Novack V; Cutlip D; Kleiman N; Pencina M; Mauri L; Yen CH; Berger P; Goldberg S; Kellett M; Waksman R; Hong M; Raizner AE; Cohen DJ JACC Cardiovasc Interv; 2009 Aug; 2(8):767-75. PubMed ID: 19695546 [TBL] [Abstract][Full Text] [Related]
12. Benefits of drug-eluting stents as compared to bare metal stent in ST-segment elevation myocardial infarction: four year results of the PaclitAxel or Sirolimus-Eluting stent vs bare metal stent in primary angiOplasty (PASEO) randomized trial. Di Lorenzo E; Sauro R; Varricchio A; Capasso M; Lanzillo T; Manganelli F; Mariello C; Siano F; Pagliuca MR; Stanco G; Rosato G; De Luca G Am Heart J; 2009 Oct; 158(4):e43-50. PubMed ID: 19781402 [TBL] [Abstract][Full Text] [Related]
13. Randomized comparison of the efficacy and safety of zotarolimus-eluting stents vs. sirolimus-eluting stents for percutaneous coronary intervention in chronic total occlusion--CAtholic Total Occlusion Study (CATOS) trial. Park HJ; Kim HY; Lee JM; Choi YS; Park CS; Kim DB; Her SH; Koh YS; Park MW; Kwon BJ; Kim PJ; Chang K; Chung WS; Seung KB Circ J; 2012; 76(4):868-75. PubMed ID: 22277317 [TBL] [Abstract][Full Text] [Related]
14. Lack of clinical benefit of improved angiographic results with sirolimus-eluting stents compared with paclitaxel and zotarolimus-eluting stents in patients with acute myocardial infarction undergoing percutaneous coronary intervention. Choi CU; Rha SW; Chen KY; Li YJ; Poddar KL; Jin Z; Minami Y; Suh SY; Na JO; Lim HE; Kim JW; Kim EJ; Park CG; Seo HS; Oh DJ Circ J; 2009 Dec; 73(12):2229-35. PubMed ID: 19789418 [TBL] [Abstract][Full Text] [Related]
15. Impact of lesion length and vessel size on clinical outcomes after percutaneous coronary intervention with everolimus- versus paclitaxel-eluting stents pooled analysis from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) and COMPARE (Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice) Randomized Trials. Claessen BE; Smits PC; Kereiakes DJ; Parise H; Fahy M; Kedhi E; Serruys PW; Lansky AJ; Cristea E; Sudhir K; Sood P; Simonton CA; Stone GW JACC Cardiovasc Interv; 2011 Nov; 4(11):1209-15. PubMed ID: 22115661 [TBL] [Abstract][Full Text] [Related]
16. Real world, long-term outcomes comparison between paclitaxel-eluting and sirolimus-eluting stent platforms. Sidhu MS; Brown JR; Yang RC; DeVries JT; Jayne JE; Hettleman BD; Friedman BJ; Niles NW; Kaplan AV; Robb JF; Malenka DJ; Thompson CA; J Interv Cardiol; 2010 Apr; 23(2):167-75. PubMed ID: 20236213 [TBL] [Abstract][Full Text] [Related]
17. Four-year clinical outcome of sirolimus- and paclitaxel-eluting stents compared to bare-metal stents for the percutaneous treatment of stable coronary artery disease. Simsek C; Onuma Y; Magro M; de Boer S; Battes L; van Domburg RT; Boersma E; Serruys PW; Catheter Cardiovasc Interv; 2010 Jul; 76(1):41-9. PubMed ID: 20310019 [TBL] [Abstract][Full Text] [Related]
18. The PASEO (PaclitAxel or Sirolimus-Eluting Stent Versus Bare Metal Stent in Primary Angioplasty) Randomized Trial. Di Lorenzo E; De Luca G; Sauro R; Varricchio A; Capasso M; Lanzillo T; Manganelli F; Mariello C; Siano F; Pagliuca MR; Stanco G; Rosato G JACC Cardiovasc Interv; 2009 Jun; 2(6):515-23. PubMed ID: 19539255 [TBL] [Abstract][Full Text] [Related]
19. Comparison of outcomes after percutaneous coronary intervention for chronic total occlusion using everolimus- versus sirolimus- versus paclitaxel-eluting stents (from the Korean National Registry of Chronic Total Occlusion Intervention). Lee MH; Lee JM; Kang SH; Yoon CH; Jang Y; Yu CW; Park HS; Lee SH; Hur SH; Kim MH; Rha SW; Gwon HC; Chae IH; Kim HS Am J Cardiol; 2015 Jul; 116(2):195-203. PubMed ID: 26001819 [TBL] [Abstract][Full Text] [Related]
20. Comparison between sirolimus- and Paclitaxel-eluting stents for the treatment of chronic total occlusions. Jang JS; Hong MK; Lee CW; Park DW; Lee BK; Kim YH; Han KH; Kim JJ; Park SW; Park SJ J Invasive Cardiol; 2006 May; 18(5):205-8. PubMed ID: 16670446 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]